►February 19, 2004 -
British
team develops Black Death vaccine - The Times, UK - "BRITISH
scientists have made a crucial breakthrough in the war on terrorism by
developing a vaccine to counter bubonic plague, the bacteria that caused the
Black Death...A vaccine for the bubonic plague, which killed millions in the
Middle Ages and is now one of the deadliest bio-terrorism agents, may be
available within a year as a result of a breakthrough at the Ministry of
Defences laboratory at Porton Down.
Comment:
Antibiotics are effective against the plague if given within 24 hours of the
first symptoms, according to the
CDC.
(Although there apparently is some concern about growing
resistance
of the plague to antibiotics.)
February 9-15, 2004
►February 11, 2004 -
Malaysian scientists in vaccine breakthrough -
www.abc.net.au - "Malaysian scientists,
working with French colleagues, have developed a trial vaccine for Nipah virus,
a new and deadly disease...The researchers injected hamsters with the
experimental vaccine, which then developed neutralising antibodies that
prevented infection...Nipah produces flu-like symptoms and often leads to
encephalitis and coma...The disease originally affected fruit bats but it has
since jumped the species barrier, first to pigs and then to humans in Malaysia
in October 1998."
January 26 - February 8, 2004 (2 weeks combined
due to illness)
►February 4, 2004 - Frightful
find a boon for one firm - Word that ricin, a poison, had been found in a
senator's office, gives a big boost to DOR BioPharma. But one expert warns
investors to be cautious. - The Miami Herald
Comment: How about
developing an antidote for ricin, to only be used by those exposed (a highly
unlikely event), rather than provide a vaccine for the masses? Or is the
cost thought to simply be too prohibitive, given the expected rarity of the
event? In which case, isn't any potential vaccine risk not worth taking?
(If the government wants to help the drug companies, how about helping them
develop the antidote, rather than covering their vaccine liability?)
Comment: As long as this vaccine is restricted to
willing users (and actually is safe and effective), it might be an example of a
reasonable product because it is targeted at people who already have (and
recognize they have) a problem. Compare that to the childhood vaccines,
which are forced on healthy children who may or may not (most likely will not)
have a problem with the disease the vaccine is alleged to (safely) prevent.
►January 7, 2004 - Hope
for leukaemia vaccine - Successful tests in mice could herald a vaccine
treatment for people with a form of leukaemia. - BBC
Comment: If this
vaccine is actually safe and effective, and is only given to those who have
leukaemia and choose to take it, just as with the "anti-nicotine" vaccine below,
it may have a meaningful role to play.
DISCLAIMER: All
information, data, and material contained, presented, or provided here is for
general information purposes only and is not to be construed as reflecting the
knowledge or opinions of the publisher, and is not to be construed or intended
as providing medical or legal advice. The decision whether or not to vaccinate
is an important and complex issue and should be made by you, and you alone, in
consultation with your health care provider.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"